The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2
Open accessAbstract
The emergence of the SARS‐CoV‐2 strain of the human coronavirus has thrown the world into the midst of a new pandemic. In the human body, the virus causes COVID‐19, a disease characterized by shortness of breath, fever, and pneumonia, which can be fatal in vulnerable individuals. SARS‐CoV‐2 has characteristics of past human coronaviruses, with close genomic similarities to SARS‐CoV, the virus that causes the disease SARS. Like these related coronaviruses, SARS‐CoV‐2 is transmitted through the inhalation of droplets and interaction with contaminated surfaces. Across the world, laboratories are developing candidate vaccines for the virus – with vaccine trials underway in the United States and the United Kingdom – and considering various drugs for possible treatments and prophylaxis. Here, we provide an overview of SARS‐CoV‐2 by analyzing its virology, epidemiology, and modes of transmission while examining the current progress of testing procedures and possible treatments through drugs and vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., Gerber, S. I., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2004973 · Cited by 9,951
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,403
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Rothan, H. A., & Byrareddy, S. N. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102433 · Cited by 5,840
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020) · Science · doi:10.1126/science.abb2762 · Cited by 5,040
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., Yu, J., Kang, M., Song, Y., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,810
Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,787
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
How will country-based mitigation measures influence the course of the COVID-19 epidemic?
Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30567-5 · Cited by 3,648
A Review of Coronavirus Disease-2019 (COVID-19)
Singhal, T. (2020) · The Indian Journal of Pediatrics · doi:10.1007/s12098-020-03263-6 · Cited by 3,537
The reproductive number of COVID-19 is higher compared to SARS coronavirus
Liu, Y., Gayle, A. A., Wilder-Smith, A., & Rocklöv, J. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa021 · Cited by 3,192
COVID-19 and Italy: what next?
Remuzzi, A., & Remuzzi, G. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30627-9 · Cited by 3,119
To, K. K.-W., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C.-Y., Cai, J.-P., Chan, J. M.-C., Chik, T. S.-H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,066
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C. K., Zhou, J., Liu, W., Bi, Y., & Gao, G. F. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.03.003 · Cited by 2,948
Coronavirus as a possible cause of severe acute respiratory syndrome
Peiris, J., Lai, S., Poon, L., Guan, Y., Yam, L., Lim, W., Nicholls, J., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,915
CDC Weekly, C., & The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · China CDC Weekly · doi:10.46234/ccdcw2020.032 · Cited by 2,889
Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,590
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
Bhatraju, P. K., Ghassemieh, B. J., Nichols, M., Kim, R., Jerome, K. R., Nalla, A. K., Greninger, A. L., Pipavath, S., Wurfel, M. M., Evans, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004500 · Cited by 2,583
Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., Holstein, R., Prill, M., Chai, S. J., Kirley, P. D., Alden, N. B., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6915e3 · Cited by 2,335
SARS control and psychological effects of quarantine, Toronto, Canada
Hawryluck, L., Gold, W. L., Robinson, S., Pogorski, S., Galea, S., & Styra, R. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1007.030703 · Cited by 1,929
COVID-19 pneumonia: different respiratory treatments for different phenotypes?
Gattinoni, L., Chiumello, D., Caironi, P., Busana, M., Romitti, F., Brazzi, L., & Camporota, L. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06033-2 · Cited by 1,852
A serological assay to detect SARS-CoV-2 seroconversion in humans
Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769
The Molecular Biology of Coronaviruses
Masters, P. S. (2006) · Advances in Virus Research · doi:10.1016/s0065-3527(06)66005-3 · Cited by 1,761
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic
(2020) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-200220-0772 · Cited by 1,537
Hu, Z., Song, C., Xu, C., Jin, G., Chen, Y., Xu, X., Ma, H., Chen, W., Lin, Y., Zheng, Y., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1661-4 · Cited by 1,412
Xia, S., Liu, M., Wang, C., Xu, W., Lan, Q., Feng, S., Qi, F., Bao, L., Du, L., Liu, S., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0305-x · Cited by 1,343
COVID-19 exacerbating inequalities in the US
Dorn, A. V., Cooney, R. E., & Sabin, M. L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30893-x · Cited by 1,315
Riou, J., & Althaus, C. L. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.4.2000058 · Cited by 1,297
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · PubMed Central · Cited by 1,278
Middle East respiratory syndrome
Zumla, A., Hui, D. S., & Perlman, S. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60454-8 · Cited by 1,263
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.04.037 · Cited by 1,237
Real-time RT-PCR in COVID-19 detection: issues affecting the results
Tahamtan, A., & Ardebili, A. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1757437 · Cited by 1,217
Quantitative RT-PCR: Pitfalls and Potential
Freeman, W. M., Walker, S. J., & Vrana, K. E. (1999) · BioTechniques · doi:10.2144/99261rv01 · Cited by 1,147
A human monoclonal antibody blocking SARS-CoV-2 infection
Wang, C., Li, W., Drabek, D., Okba, N. M. A., van Haperen, R., Osterhaus, A. D. M. E., van Kuppeveld, F. J. M., Haagmans, B. L., Grosveld, F., & Bosch, B.-J. (2020) · Nature Communications · doi:10.1038/s41467-020-16256-y · Cited by 1,132
SARS-CoV-2 Vaccines: Status Report
Amanat, F., & Krammer, F. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.007 · Cited by 1,120
Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19
Gandhi, M., Yokoe, D. S., & Havlir, D. V. (2020) · New England Journal of Medicine · doi:10.1056/nejme2009758 · Cited by 1,094
Sheahan, T. P., Sims, A. C., Zhou, S., Graham, R. L., Pruijssers, A. J., Agostini, M. L., Leist, S. R., Schäfer, A., Dinnon, K. H., Stevens, L. J., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abb5883 · Cited by 1,071
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
FURUTA, Y., KOMENO, T., & NAKAMURA, T. (2017) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.93.027 · Cited by 1,070
Astuti, I., & Ysrafil (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.020 · Cited by 1,070
Yang, C., Zhao, H., Bruzzone, L., Benediktsson, J. A., Liang, Y., Liu, B., Zeng, X., Guan, R., Li, C., & Ouyang, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-20215-y · Cited by 1,052
Scientific and ethical basis for social-distancing interventions against COVID-19
Lewnard, J. A., & Lo, N. C. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30190-0 · Cited by 935
Complexity of the Basic Reproduction Number (R0)
Delamater, P. L., Street, E. J., Leslie, T. F., Yang, Y. T., & Jacobsen, K. H. (2019) · Emerging Infectious Diseases · doi:10.3201/eid2501.171901 · Cited by 860
The estimation of the basic reproduction number for infectious diseases
Dietz, K. (1993) · Statistical Methods in Medical Research · doi:10.1177/096228029300200103 · Cited by 829
Gaunt, E. R., Hardie, A., Claas, E. C. J., Simmonds, P., & Templeton, K. E. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00636-10 · Cited by 699
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19
Magagnoli, J., Narendran, S., Pereira, F., Cummings, T. H., Hardin, J. W., Sutton, S. S., & Ambati, J. (2020) · Med · doi:10.1016/j.medj.2020.06.001 · Cited by 656
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
Tchesnokov, E. P., Feng, J. Y., Porter, D. P., & Götte, M. (2019) · Viruses · doi:10.3390/v11040326 · Cited by 622
History and Recent Advances in Coronavirus Discovery
Kahn, J. S., & McIntosh, K. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000188166.17324.60 · Cited by 619
CHAN‐YEUNG, M., & XU, R. (2003) · Respirology · doi:10.1046/j.1440-1843.2003.00518.x · Cited by 577
Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies
Li, F. (2015) · Journal of Virology · doi:10.1128/jvi.02615-14 · Cited by 573
New insights into the antiviral effects of chloroquine
Savarino, A., Di Trani, L., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570
Mahévas, M., Tran, V.-T., Roumier, M., Chabrol, A., Paule, R., Guillaud, C., Fois, E., Lepeule, R., Szwebel, T.-A., Lescure, F.-X., et al. (2020) · BMJ · doi:10.1136/bmj.m1844 · Cited by 566
Type 1 interferons as a potential treatment against COVID-19
Sallard, E., Lescure, F.-X., Yazdanpanah, Y., Mentre, F., & Peiffer-Smadja, N. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104791 · Cited by 509
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
Abbott, T. R., Dhamdhere, G., Liu, Y., Lin, X., Goudy, L., Zeng, L., Chemparathy, A., Chmura, S., Heaton, N. S., Debs, R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.020 · Cited by 498
The establishment of reference sequence for SARS‐CoV‐2 and variation analysis
Wang, C., Liu, Z., Chen, Z., Huang, X., Xu, M., He, T., & Zhang, Z. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25762 · Cited by 494
2019 Novel Coronavirus (COVID-19) Pandemic: Built Environment Considerations To Reduce Transmission
Dietz, L., Horve, P. F., Coil, D. A., Fretz, M., Eisen, J. A., & Van Den Wymelenberg, K. (2020) · mSystems · doi:10.1128/msystems.00245-20 · Cited by 491
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
Lokugamage, K. G., Hage, A., de Vries, M., Valero-Jimenez, A. M., Schindewolf, C., Dittmann, M., Rajsbaum, R., & Menachery, V. D. (2020) · Journal of Virology · doi:10.1128/jvi.01410-20 · Cited by 483
Lopinavir/Ritonavir: A Review of its Use in the Management of HIV Infection
Cvetkovic, R. S., & Goa, K. L. (2003) · Drugs · doi:10.2165/00003495-200363080-00004 · Cited by 436
COVID-19: the case for health-care worker screening to prevent hospital transmission
Black, J. R. M., Bailey, C., Przewrocka, J., Dijkstra, K. K., & Swanton, C. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30917-x · Cited by 416
He, Y., Zhou, Y., Liu, S., Kou, Z., Li, W., Farzan, M., & Jiang, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.106 · Cited by 403
Angiotensin-converting enzyme 2 in lung diseases
KUBA, K., IMAI, Y., & PENNINGER, J. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.03.001 · Cited by 401
COVID-19 in Singapore—Current Experience: Critical Global Issues That Require Attention and Action
Wong, J. E. L., Leo, Y. S., & Tan, C. C. (2020) · JAMA · doi:10.1001/jama.2020.2467 · Cited by 398
Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner
Burkard, C., Verheije, M. H., Wicht, O., van Kasteren, S. I., van Kuppeveld, F. J., Haagmans, B. L., Pelkmans, L., Rottier, P. J. M., Bosch, B. J., & de Haan, C. A. M. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004502 · Cited by 388
Race to find COVID-19 treatments accelerates
Kupferschmidt, K., & Cohen, J. (2020) · Science · doi:10.1126/science.367.6485.1412 · Cited by 378
Interferon pathway in SLE: one key to unlocking the mystery of the disease
Rönnblom, L., & Leonard, D. (2019) · Lupus Science & Medicine · doi:10.1136/lupus-2018-000270 · Cited by 362
Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR–Cas Systems
O'Connell, M. R. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.029 · Cited by 346
Epidemiologic Clues to SARS Origin in China
Xu, R.-H., He, J.-F., Evans, M. R., Peng, G.-W., Field, H. E., Yu, D.-W., Lee, C.-K., Luo, H.-M., Lin, W.-S., Lin, P., et al. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1006.030852 · Cited by 332
Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020
Perera, R. A., Mok, C. K., Tsang, O. T., Lv, H., Ko, R. L., Wu, N. C., Yuan, M., Leung, W. S., Chan, J. M., Chik, T. S., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.16.2000421 · Cited by 322
MERS-CoV spike protein: a key target for antivirals
Du, L., Yang, Y., Zhou, Y., Lu, L., Li, F., & Jiang, S. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1271415 · Cited by 301
Public health interventions and SARS spread, 2003
Bell, D. M., & World Health Organization Working Group on Prevention of International and Community Transmission of SARS (2004) · Emerging Infectious Diseases · doi:10.3201/eid1011.040729 · Cited by 272
Kelso, J. K., Milne, G. J., & Kelly, H. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-117 · Cited by 260
Human Coronavirus NL63, France
Vabret, A., Mourez, T., Dina, J., van der Hoek, L., Gouarin, S., Petitjean, J., Brouard, J., & Freymuth, F. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1108.050110 · Cited by 252
Wong, S. C. Y., Kwong, R. T.-S., Wu, T. C., Chan, J. W. M., Chu, M. Y., Lee, S. Y., Wong, H. Y., & Lung, D. C. (2020) · Journal of Hospital Infection · doi:10.1016/j.jhin.2020.03.036 · Cited by 241
Middle East Respiratory Syndrome Coronavirus Transmission
Killerby, M. E., Biggs, H. M., Midgley, C. M., Gerber, S. I., & Watson, J. T. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2602.190697 · Cited by 232
Exploring the trade-offs between electric heating policy and carbon mitigation in China
Wang, J., Zhong, H., Yang, Z., Wang, M., Kammen, D. M., Liu, Z., Ma, Z., Xia, Q., & Kang, C. (2020) · Nature Communications · doi:10.1038/s41467-020-19854-y · Cited by 227
Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry
Shirato, K., Kawase, M., & Matsuyama, S. (2018) · Virology · doi:10.1016/j.virol.2017.11.012 · Cited by 225
Lau, A. L. D., Chi, I., Cummins, R. A., Lee, T. M. C., Chou, K.-L., & Chung, L. W. M. (2008) · Aging & Mental Health · doi:10.1080/13607860802380607 · Cited by 217
Qiu, Y., Zhao, Y.-B., Wang, Q., Li, J.-Y., Zhou, Z.-J., Liao, C.-H., & Ge, X.-Y. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.03.003 · Cited by 216
Live bacterial vaccines--a review and identification of potential hazards.
Detmer, A. M., & Glenting, J. (2006) · Microbial Cell Factories · doi:10.1186/1475-2859-5-23 · Cited by 191
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
He, J., Tao, H., Yan, Y., Huang, S.-Y., & Xiao, Y. (2020) · Viruses · doi:10.3390/v12040428 · Cited by 187
Lateral flow based immunobiosensors for detection of food contaminants
Raeisossadati, M. J., Danesh, N. M., Borna, F., Gholamzad, M., Ramezani, M., Abnous, K., & Taghdisi, S. M. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.06.061 · Cited by 181
Gao, J., Lu, G., Qi, J., Li, Y., Wu, Y., Deng, Y., Geng, H., Li, H., Wang, Q., Xiao, H., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02433-13 · Cited by 175
SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission
Bolles, M., Donaldson, E., & Baric, R. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.012 · Cited by 166
Konrad, R., Eberle, U., Dangel, A., Treis, B., Berger, A., Bengs, K., Fingerle, V., Liebl, B., Ackermann, N., & Sing, A. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.9.2000173 · Cited by 158
Kapadia, S. U., Rose, J. K., Lamirande, E. W., Vogel, L., Subbarao, K., & Roberts, A. (2005) · Virology · doi:10.1016/j.virol.2005.06.016 · Cited by 155
Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013
Nowotny, N. R., & Kolodziejek, J. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.16.20781 · Cited by 149
Recently Discovered Human Coronaviruses
Wevers, B. A., & van der Hoek, L. (2009) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2009.07.007 · Cited by 127
Clinical review: fever in intensive care unit patients.
Ryan, M., & Levy, M. M. (2003) · Critical Care · doi:10.1186/cc1879 · Cited by 126
RNA-Targeting CRISPR-Cas systems and their applications
Burmistrz, M., Krakowski, K., & Krawczyk-Balska, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031122 · Cited by 125
Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives.
Infantino, M. G., Damiani, A., Gobbi, F. L., Grossi, V., Lari, B., Macchia, D., Casprini, P., Veneziani, F., Villalta, D., Bizzaro, N., et al. (2020) · PubMed · Cited by 123
The Final Size of an Epidemic and Its Relation to the Basic Reproduction Number
Andreasen, V. (2011) · Bulletin of Mathematical Biology · doi:10.1007/s11538-010-9623-3 · Cited by 120
Mechanisms of Severe Acute Respiratory Syndrome Pathogenesis and Innate Immunomodulation
Frieman, M. B., & Baric, R. S. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00015-08 · Cited by 117
Vaccine Delivery Methods Using Viral Vectors
Bråve, A., Ljungberg, K., Wahrén, B., & Liu, M. A. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060098+ · Cited by 114
Al-Muharraqi, M. A. (2020) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2020.04.014 · Cited by 106
RNA Viruses: RNA Roles in Pathogenesis, Coreplication and Viral Load
Poltronieri, P., Sun, B., & Mallardo, M. (2015) · Current Genomics · doi:10.2174/1389202916666150707160613 · Cited by 102
Moore, N. M., Li, H., Schejbal, D., Lindsley, J., & Hayden, M. K. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00938-20 · Cited by 78
Recent advances in mRNA vaccine delivery
Tan, L., & Sun, X. (2018) · Nano Research · doi:10.1007/s12274-018-2091-z · Cited by 77
Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice
Jin, H., Xiao, C., Chen, Z., Kang, Y., Ma, Y., Zhu, K., Xie, Q., Tu, Y.-X., Yu, Y., & Wang, B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.048 · Cited by 69
SARS Transmission and Commercial Aircraft
Breugelmans, J. G., Zucs, P., Porten, K., Broll, S., Niedrig, M., Ammon, A., & Krause, G. (2004) · Emerging infectious diseases · doi:10.3201/eid1008.040093 · Cited by 64
The Role of Hydroxychloroquine in COVID-19 Treatment: A Systematic Review and Meta-Analysis
Shamshirian, A., Hessami, A., Heydari, K., Alizadeh‐Navaei, R., Ebrahimzadeh, M. A., Yip, G. W. C., Ghasemian, R., Sedaghat, M., Baradaran, H., Yazdii, S. M., et al. (2020) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmed.sg.2020370 · Cited by 46
Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenzaPreprint
Abbott, T. R., Dhamdhere, G. R., Liu, Y., Lin, X., Goudy, L., Zeng, L., Chemparathy, A. G., Chmura, S. A., Heaton, N. S., Debs, R. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.13.991307 · Cited by 30
Bridge, J. A. (2016) · Cancer Cytopathology · doi:10.1002/cncy.21762 · Cited by 29
Xia, T., Li, J., Gao, J., & Xu, X. (2020) · Korean Journal of Radiology · doi:10.3348/kjr.2020.0240 · Cited by 27
Young, P. J., Bailey, M., Bass, F. E., Beasley, R. W., Freebairn, R., Hammond, N. E., van Haren, F. M. P., Harward, M. L., Henderson, S. J., Mackle, D., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05729-4 · Cited by 26
“Less is More” in mechanical ventilation
Gattinoni, L., Quintel, M., & Marini, J. J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05981-z · Cited by 26
Ahmed, A. E. (2017) · Epidemiology and Infection · doi:10.1017/s095026881700293x · Cited by 25
Cited by
Plant-Derived Nanovesicles: Further Exploration of Biomedical Function and Application Potential
Li, A., Li, D., Gu, Y., Liu, R., Tang, X., Zhao, Y., Qi, F., Wei, J., & Liu, J. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.022 · Cited by 137
Metadata
- Authors
- Atzrodt, C. L., Maknojia, I., McCarthy, R. D. P., Oldfield, T. M., Po, J., Ta, K. T. L., Stepp, H. E., & Clements, T. P.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2020-06-16
- Volume
- 287
- Issue
- 17
- Pages
- 3633-3650
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W3028010531
- Cited by
- 341
- References
- 120
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
